Identification of protein clusters predictive of response to chemotherapy in breast cancer patients

Journal of Proteome Research

Volumn 8, Issue 11, 2009, Pages 4916-4933

  Cortesi, Laura ^a   Barchetti, Andrea ^a   De Matteis, Elisabetta ^a   Rossi, Elena ^a   Della Casa, Lara ^a   Marcheselli, Luigi ^a   Tazzioli, Giovanni ^a   Lazzaretti, Maria Grazia ^b   Ficarra, Guido ^a   Federico, Massimo ^a   Iannone, Anna ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b B Ramazzini Hospital   (Italy)

Author keywords

Biomarkers; Breast cancer; Chemotherapy; Tumor interstitial fluid

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; HUMAN; INTERSTITIAL FLUID; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEOMICS; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; UNINDEXED SEQUENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXTRACELLULAR FLUID; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 70449358615     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900239h     Document Type: Article

References (48)

1. Anderson, L.; Seilhamer, J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997, 18, 533-537 (Pubitemid 27174443)
2. Chen, G.; Gharib, T. G.; Wang, H.; Huang, C. C.; Kuick, R.; Thomas, D. G.; Shedden, K. A.; Misek, D. E.; Taylor, J. M.; Giordano, T. J.; Kardia, S. L.; Iannettoni, M. D.; Yee, J.; Hogg, P. J.; Orringer, M. B.; Hanash, S. M.; Beer, D. G. Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13537-13542
3. Ginestier, C.; Charafe-Jauffret, E.; Bertucci, F.; Eisinger, F.; Geneix, J.; Bechlian, D.; Conte, N.; Adelaide, J.; Toiron, Y.; Nguyen, C.; Viens, P.; Mozziconacci, M. J.; Houlgatte, R.; Birnbaum, D.; Jacquemier, J. Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am. J. Pathol. 2002, 161, 1223-1233
4. Gygi, S. P.; Rochon, Y.; Franza, B. R.; Aebersold, R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 1999, 19, 1720-1730 (Pubitemid 29098230)
5. Nishizuka, S.; Charboneau, L.; Young, L.; Major, S.; Reinhold, W. C.; Waltham, M.; Kouros-Mehr, H.; Bussey, K. J.; Lee, J. K.; Espina, V.; Munson, P. J.; Petricoin, E., III; Liotta, L. A.; Weinstein, J. N. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 14229-14234
6. Tyers, M.; Mann, M. From genomics to proteomics. Nature 2003, 422, 193-197
7. Hondermarck, H.; Vercoutter-Edouart, A. S.; Revillion, F.; Lemoine, J.; el-Yazidi-Belkoura, I.; Nurcombe, V.; Peyrat, J. P. Proteomics of breast cancer for marker discovery and signal pathway profiling. Proteomics 2001, 1, 1216-1232
8. Dwek, M. V.; Alaiya, A. A. Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues. Br. J. Cancer 2003, 89, 305-307
9. Wiseman, B. S.; Werb, Z. Stromal effects on mammary gland development and breast cancer. Science 2002, 296, 1046-1049 (Pubitemid 34517108)
10. Silberstein, G. B. Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Res 2001, 3, 218-223
11. Coussens, L. M.; Werb, Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996, 3, 895-904.
12. Coussens, L. M.; Werb, Z. Inflammatory cells and cancer: think different! J. Exp. Med. 2001, 193, F23-6. (Pubitemid 32524459)
13. Fidler, I. J. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment. J. Natl. Cancer Inst. 2001, 93, 1040-1041
14. Fidler, I. J. Regulation of neoplastic angiogenesis. J. Natl. Cancer Inst. Monogr. 2001, 10, 4.
15. Ma, X. J.; Dahiya, S.; Richardson, E.; Erlander, M.; Sgroi, D. C. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009, 11, R7.
16. Robinson, B. D.; Sica, G. L.; Liu, Y. F.; Rohan, T. E.; Gertler, F. B.; Condeelis, J. S.; Jones, J. G. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin. Cancer Res. 2009, 15, 2433-2441
17. Celis, J. E.; Gromov, P.; Cabezon, T.; Moreira, J. M.; Ambartsumian, N.; Sandelin, K.; Rank, F.; Gromova, I. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol. Cell. Proteomics 2004, 3, 327-344
18. Celis, J. E.; Moreira, J. M.; Cabezon, T.; Gromov, P.; Friis, E.; Rank, F.; Gromova, I. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell. Proteomics 2005, 4, 492-522.
19. Gutman, S.; Kessler, L. G. The US Food and Drug Administration perspective on cancer biomarker development. Nat. Rev. Cancer 2006, 6, 565-571 (Pubitemid 43980545)
20. Stronach, E. A.; Sellar, G. C.; Blenkiron, C.; Rabiasz, G. J.; Taylor, K. J.; Miller, E. P.; Massie, C. E.; Al-Nafussi, A.; Smyth, J. F.; Porteous, D. J.; Gabra, H. Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res. 2003, 63, 8648-8655
21. Tan, E. Y.; Yan, M.; Campo, L.; Han, C.; Takano, E.; Turley, H.; Candiloro, I.; Pezzella, F.; Gatter, K. C.; Millar, E. K.; O'Toole, S. A.; McNeil, C. M.; Crea, P.; Segara, D.; Sutherland, R. L.; Harris, A. L.; Fox, S. B. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br. J. Cancer 2009, 100, 405-411
22. Hussain, S. A.; Ganesan, R.; Reynolds, G.; Gross, L.; Stevens, A.; Pastorek, J.; Murray, P. G.; Perunovic, B.; Anwar, M. S.; Billingham, L.; James, N. D.; Spooner, D.; Poole, C. J.; Rea, D. W.; Palmer, D. H. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br. J. Cancer 2007, 96, 104-109
23. Span, P. N.; Bussink, J.; De Mulder, P. H.; Sweep, F. C. Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer. Br. J. Cancer 2007, 96, 1309, author reply 1310.
24. Watson, P. H.; Chia, S. K.; Wykoff, C. C.; Han, C.; Leek, R. D.; Sly, W. S.; Gatter, K. C.; Ratcliffe, P.; Harris, A. L. Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. Br. J. Cancer 2003, 88, 1065-1070
25. Parkkila, S.; Rajaniemi, H.; Parkkila, A. K.; Kivela, J.; Waheed, A.; Pastorekova, S.; Pastorek, J.; Sly, W. S. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci U S A 2000, 97, 2220-2224
26. Bekku, S.; Mochizuki, H.; Yamamoto, T.; Ueno, H.; Takayama, E.; Tadakuma, T. Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology 2000, 47, 998-1001. (Pubitemid 30746240)
27. Lankat-Buttgereit, B.; Gregel, C.; Knolle, A.; Hasilik, A.; Arnold, R.; Goke, R. Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol. Cell. Endocrinol. 2004, 214, 149-153 (Pubitemid 38210124)
28. Chuthapisith, S.; Eremin, J. M.; Eremin, O. Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers, and the cancer metabolome. Oncol. Rep. 2008, 20, 699-703.
29. Maekawa, M.; Taniguchi, T.; Ishikawa, J.; Sugimura, H.; Sugano, K.; Kanno, T. Promoter hypermethylation in cancer silences LDHB, eliminating lactate dehydrogenase isoenzymes 1-4. Clin. Chem. 2003, 49, 1518-1520 (Pubitemid 37011741)
30. Maekawa, M.; Inomata, M.; Sasaki, M. S.; Kaneko, A.; Ushiama, M.; Sugano, K.; Takayama, J.; Kanno, T. Electrophoretic variant of a lactate dehydrogenase isoenzyme and selective promoter methylation of the LDHA gene in a human retinoblastoma cell line. Clin. Chem. 2002, 48, 1938-1945 (Pubitemid 35222752)
31. Chen, Y.; Zhang, H.; Xu, A.; Li, N.; Liu, J.; Liu, C.; Lv, D.; Wu, S.; Huang, L.; Yang, S.; He, D.; Xiao, X. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer 2006, 54, 95-102.
32. Lu, H. S.; Yuan, P. M.; Gracy, R. W. Primary structure of human triosephosphate isomerase. J. Biol. Chem. 1984, 259, 11958-11968 (Pubitemid 14022124)
33. Zhang, D.; Tai, L. K.; Wong, L. L.; Chiu, L. L.; Sethi, S. K.; Koay, E. S. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neupositive breast cancer. Mol. Cell. Proteomics 2005, 4, 1686-1696
34. Lichtenfels, R.; Kellner, R.; Atkins, D.; Bukur, J.; Ackermann, A.; Beck, J.; Brenner, W.; Melchior, S.; Seliger, B. Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses. Biochim. Biophys. Acta 2003, 1646, 21-31. (Pubitemid 38234688)
35. Brown, L. F.; Asch, B.; Harvey, V. S.; Buchinski, B.; Dvorak, H. F. Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas. Cancer Res. 1988, 48, 1920-1925 (Pubitemid 18100173)
36. Costantini, V.; Zacharski, L. R.; Memoli, V. A.; Kisiel, W.; Kudryk, B. J.; Rousseau, S. M. Fibrinogen deposition without thrombin generation in primary human breast cancer tissue. Cancer Res. 1991, 51, 349-353
37. Wojtukiewicz, M. Z.; Zacharski, L. R.; Memoli, V. A.; Kisiel, W.; Kudryk, B. J.; Rousseau, S. M.; Stump, D. C. Absence of components of coagulation and fibrinolysis pathways in situ in mesothelioma. Thromb. Res. 1989, 55, 279-284
38. Wojtukiewicz, M. Z.; Zacharski, L. R.; Memoli, V. A.; Kisiel, W.; Kudryk, B. J.; Rousseau, S. M.; Stump, D. C. Indirect activation of blood coagulation in colon cancer. Thromb. Haemostasis 1989, 62, 1062-1066
39. Costantini, V.; Zacharski, L. R.; Memoli, V. A.; Kisiel, W.; Kudryk, B. J.; Rousseau, S. M.; Stump, D. C. Fibrinogen deposition and macrophage- associated fibrin formation in malignant and nonmalignant lymphoid tissue. J. Lab. Clin. Med. 1992, 119, 124-131
40. Rybarczyk, B. J.; Simpson-Haidaris, P. J. Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res. 2000, 60, 2033-2039
41. Kavallaris, M.; Kuo, D. Y.; Burkhart, C. A.; Regl, D. L.; Norris, M. D.; Haber, M.; Horwitz, S. B. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J. Clin. Invest. 1997, 100, 1282-1293
42. Verdier-Pinard, P.; Wang, F.; Martello, L.; Burd, B.; Orr, G. A.; Horwitz, S. B. Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry. Biochemistry 2003, 42, 5349-5357
43. Galmarini, C. M.; Kamath, K.; Vanier-Viornery, A.; Hervieu, V.; Peiller, E.; Falette, N.; Puisieux, A.; Ann Jordan, M.; Dumontet, C. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. Br. J. Cancer 2003, 88, 1793-1799 (Pubitemid 36760426)
44. Galmarini, C. M.; Treilleux, I.; Cardoso, F.; Bernard-Marty, C.; Durbecq, V.; Gancberg, D.; Bissery, M. C.; Paesmans, M.; Larsimont, D.; Piccart, M. J.; Di Leo, A.; Dumontet, C. Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel. Clin. Cancer Res. 2008, 14, 4511-4516
45. Thomas, P. A.; Kirschmann, D. A.; Cerhan, J. R.; Folberg, R.; Seftor, E. A.; Sellers, T. A.; Hendrix, M. J. Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin. Cancer Res. 1999, 5, 2698-2703
46. Bindels, S.; Mestdagt, M.; Vandewalle, C.; Jacobs, N.; Volders, L.; Noel, A.; van Roy, F.; Berx, G.; Foidart, J. M.; Gilles, C. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 2006, 25, 4975-4985 (Pubitemid 44246356)
47. Gilles, C.; Polette, M.; Mestdagt, M.; Nawrocki-Raby, B.; Ruggeri, P.; Birembaut, P.; Foidart, J. M. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 2003, 63, 2658-2664 (Pubitemid 36605210)
48. Minard, M. E.; Ellis, L. M.; Gallick, G. E. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin. Exp. Metastasis 2006, 23, 301-313 (Pubitemid 44777570)